Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET

Core Viewpoint - Agios Pharmaceuticals, Inc. will host a conference call and live webcast on February 12, 2026, to report its fourth quarter and full year 2025 financial results and business highlights [1]. Company Overview - Agios Pharmaceuticals is a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases [1]. - The company aims to redefine the future of rare disease treatment by building trusted partnerships and collaborating to develop transformative medicines [3]. - Agios is headquartered in Cambridge, Massachusetts, and has a foundation in hematology, combining biological expertise with real-world insights to advance its pipeline of rare disease medicines [3]. Event Details - The live webcast will be accessible on the Investors section of Agios' website under the "Events & Presentations" tab [2]. - A replay of the webcast will be available approximately two hours after the event on the company's website [2]. Contacts - Investor Contact: Morgan Sanford, Vice President, Investor Relations, Agios Pharmaceuticals [4]. - Media Contact: Eamonn Nolan, Senior Director, Corporate Communications, Agios Pharmaceuticals [4].